Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

If it feels like everyone is getting the flu, you're not imagining it. This is shaping up to be another severe flu season. That's why it's important to take advantage of every tool we have to keep the ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...

The federal government program that mailed free at-home COVID-19 tests to households is no longer active. Some insurance providers may still cover the cost of at-home tests, and free tests may be ...

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--LinusBio, a leader in exposomic sequencing and precision health, today announced the publication of a study in The Lancet’s eBioMedicine that demonstrates a ...

LinusBio's groundbreaking biochemical test marks the company's first international expansion, bringing early autism screening to Japanese families and healthcare providers ClearStrand-ASD requires ...

Abstract: Plant specialized 1,4-naphthoquinones are a class of metabolites that mediate diverse plant-biotic interactions. Their convergent evolution across multiple plant lineages highlights the ...

A new concept of kinetic modules in biochemical networks could revolutionize the understanding of how these networks function. Scientists succeeded in linking the structure and dynamics of biochemical ...

A test designed to identify biomarkers associated with autism in infants and young children is now available to the public in most states. LinusBio, a New Jersey-based startup, on Thursday launched ...

A test designed to identify biomarkers associated with autism just became available in most states. The test is meant to help physicians rule out autism in children who have higher likelihoods of it.